Cargando…
'Linkage' pharmaceutical evergreening in Canada and Australia
'Evergreening' is not a formal concept of patent law. It is best understood as a social idea used to refer to the myriad ways in which pharmaceutical patent owners utilise the law and related regulatory processes to extend their high rent-earning intellectual monopoly privileges, particula...
Autores principales: | Faunce, Thomas A, Lexchin, Joel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1894804/ https://www.ncbi.nlm.nih.gov/pubmed/17543113 http://dx.doi.org/10.1186/1743-8462-4-8 |
Ejemplares similares
-
CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
por: Lexchin, Joel, et al.
Publicado: (2014) -
Models for financing the regulation of pharmaceutical promotion
por: Lexchin, Joel
Publicado: (2012) -
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal
por: Faunce, Thomas A
Publicado: (2007) -
Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good
por: Faunce, Thomas Alured
Publicado: (2006) -
Canada and access to medicines in developing countries: intellectual property rights first
por: Lexchin, Joel
Publicado: (2013)